| Bioactivity | α7 nAchR-JAK2-STAT3 agonist 1 is a potent α7 nAchR-JAK2-STAT3 agonist, with an IC50 value of 0.32 μM for nitric oxide (NO). α7 nAchR-JAK2-STAT3 agonist 1 effectively suppresses the expression of iNOS, IL-1β, and IL-6 in murine RAW264.7 macrophages. α7 nAchR-JAK2-STAT3 agonist 1 can inhibit LPS-induced NO release, NF-κB activation and cytokine production. α7 nAchR-JAK2-STAT3 can be used for researching sepsis[1]. |
| Target | IC50: 0.32 μM (NO) |
| Name | α7 nAchR-JAK2-STAT3 agonist 1 |
| CAS | 2108714-20-9 |
| Formula | C25H30O6 |
| Molar Mass | 426.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lin Y, et al. Discovery of diarylheptanoids that activate α7 nAchR-JAK2-STAT3 signaling in macrophages with anti-inflammatory activity in vitro and in vivo. Bioorg Med Chem. 2022;66:116811. |
α7 nAchR-JAK2-STAT3 agonist 1
CAS: 2108714-20-9 F: C25H30O6 W: 426.50
α7 nAchR-JAK2-STAT3 agonist 1 is a potent α7 nAchR-JAK2-STAT3 agonist, with an IC50 value of 0.32 μM for nitric oxide
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.